These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 20051470)

  • 1. Free holiday is offered to volunteers willing to test diarrhoea vaccine.
    Lenzer J
    BMJ; 2010 Jan; 340():c49. PubMed ID: 20051470
    [No Abstract]   [Full Text] [Related]  

  • 2. Preface.
    Walker RI; Riddle MS; Clifford A
    Vaccine; 2019 Aug; 37(34):4767. PubMed ID: 31300286
    [No Abstract]   [Full Text] [Related]  

  • 3. Combination vaccine strategies to prevent enteric infections.
    Walker R; Dull P
    Vaccine; 2017 Dec; 35(49 Pt A):6790-6792. PubMed ID: 28705515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical endpoints for efficacy studies.
    Porter CK; Gutierrez RL; Kotloff KL
    Vaccine; 2019 Aug; 37(34):4814-4822. PubMed ID: 30981626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A review of the current status of enteric vaccines.
    Levine MM; Noriega F
    P N G Med J; 1995 Dec; 38(4):325-31. PubMed ID: 9522876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaccines against enterotoxigenic Escherichia coli.
    Svennerholm AM; Tobias J
    Expert Rev Vaccines; 2008 Aug; 7(6):795-804. PubMed ID: 18665777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaccines to prevent travelers' diarrhea.
    Levine MM
    Ther Umsch; 1983 Mar; 40(3):253-6. PubMed ID: 6344308
    [No Abstract]   [Full Text] [Related]  

  • 8. Enteric vaccines for resource-limited countries: current status and future prospects.
    Desai SN; Sahastrabuddhe S; Ochiai RL; Wierzba TF
    Pediatr Ann; 2011 Jul; 40(7):351-7. PubMed ID: 21736257
    [No Abstract]   [Full Text] [Related]  

  • 9. Construction and phase I clinical evaluation of the safety and immunogenicity of a candidate enterotoxigenic Escherichia coli vaccine strain expressing colonization factor antigen CFA/I.
    Turner AK; Beavis JC; Stephens JC; Greenwood J; Gewert C; Thomas N; Deary A; Casula G; Daley A; Kelly P; Randall R; Darsley MJ
    Infect Immun; 2006 Feb; 74(2):1062-71. PubMed ID: 16428753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness in prevention of travellers' diarrhoea by an oral cholera vaccine WC/rBS.
    López-Gigosos R; García-Fortea P; Reina-Doña E; Plaza-Martín E
    Travel Med Infect Dis; 2007 Nov; 5(6):380-4. PubMed ID: 17983977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New vaccines against bacterial enteric infections.
    Holmgren J; Svennerholm AM
    Scand J Infect Dis Suppl; 1990; 70():149-56. PubMed ID: 2287897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A double-blind, placebo-controlled trial to evaluate the efficacy of PTL-003, an attenuated enterotoxigenic E. coli (ETEC) vaccine strain, in protecting against challenge with virulent ETEC.
    McKenzie R; Darsley M; Thomas N; Randall R; Carpenter C; Forbes E; Finucane M; Sack RB; Hall E; Bourgeois AL
    Vaccine; 2008 Aug; 26(36):4731-9. PubMed ID: 18602960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Considerations on the control of infectious diarrhea].
    Simmons SW; Goodwin MH
    Bol Oficina Sanit Panam; 1966 Apr; 60(4):293-9. PubMed ID: 4222502
    [No Abstract]   [Full Text] [Related]  

  • 14. Community perceptions of bloody diarrhoea in an urban slum in South Asia: implications for introduction of a Shigella vaccine.
    Arvelo W; Blum LS; Nahar N; von Seidlein L; Nahar L; Pack RP; Brooks AW; Pach A; Breiman RF; Luby SP; Ram PK
    Epidemiol Infect; 2011 Apr; 139(4):599-605. PubMed ID: 20546637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enterotoxigenic Escherichia coli: advances in technical and laboratory aspects of research and development of vaccines.
    Wkly Epidemiol Rec; 2008 Mar; 83(10):92-5. PubMed ID: 18326111
    [No Abstract]   [Full Text] [Related]  

  • 16. Prevention of travelers' diarrhea with trimethoprim-sulfamethoxazole and trimethoprim alone.
    DuPont HL; Galindo E; Evans DG; Cabada FJ; Sullivan P; Evans DJ
    Gastroenterology; 1983 Jan; 84(1):75-80. PubMed ID: 6336616
    [No Abstract]   [Full Text] [Related]  

  • 17. Prime-boost vaccine regimen confers protective immunity to human-derived enterotoxigenic Escherichia coli.
    Lasaro MO; Luiz WB; Sbrogio-Almeida ME; Ferreira LC
    Vaccine; 2005 Mar; 23(19):2430-8. PubMed ID: 15752829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Vaccination against the enterobacteria responsible for enteric infections].
    Sansonetti PJ
    Ann Gastroenterol Hepatol (Paris); 1994; 30(2):60-3. PubMed ID: 8210205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microbial-gut interactions in health and disease. Progress in enteric vaccine development.
    Svennerholm AM; Steele D
    Best Pract Res Clin Gastroenterol; 2004 Apr; 18(2):421-45. PubMed ID: 15123079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Immunogenicity and sensitizing properties of sexual recombinants of E. coli and Sh. flexneri].
    Motavkina NS
    Biull Eksp Biol Med; 1966 Jul; 62(7):74-8. PubMed ID: 4914973
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.